ABCs Report: Neisseria meningitidis, 2015
This website is archived for historical purposes and is no longer being maintained or updated.
March 8, 2016: Content on this page kept for historical reasons.
Active Bacterial Core Surveillance (ABCs): Emerging Infections Program Network
Print-friendly version of this surveillance report [1 page]
¶Surveillance Note
Missing race (n=8) data were multiply imputed using sequential regression imputation methods.
ABCs Areas
California (3 county San Francisco Bay area); Colorado (5 county Denver area); Connecticut; Georgia; Maryland; Minnesota; New Mexico; New York (15 county Rochester and Albany areas); Oregon; Tennessee (20 counties)
ABCs Population
The surveillance areas represent 43,912,997 persons.
Source: National Center for Health Statistics bridged-race vintage 2015 postcensal file
ABCs Case Definition
Meningococcal disease: isolation of Neisseria meningitidis from normally sterile site in a resident of a surveillance area in 2015.
ABCs Methodology
ABCs personnel routinely contacted all microbiology laboratories serving acute care hospitals in their area to identify cases. Standardized case report forms that include information on demographic characteristics, clinical syndrome, and outcome of illness were completed for each identified case. Serogrouping of meningococcal isolates was done at CDC and state laboratories. Regular laboratory audits assessed completeness of active surveillance and detected additional cases.
All rates of meningococcal disease were calculated using population estimates for 2015 from the bridged-race vintage 2015 postcensal file. For national estimates of cases and deaths, race- and age-specific rates of disease were applied from the aggregate surveillance area to the age and racial distribution of the 2015 U.S. population for 49 states (excluding Oregon due to an outbreak of serogroup B disease). The Oregon reported cases were then added to obtain the national estimates. Cases with missing data, excluding ethnicity, were multiply imputed using sequential regression imputation methods.¶
Reported ABCs Profiles
Race | No. | (Rate*) |
---|---|---|
White | 51 | (0.16) |
Black | 14 | (0.18) |
Other | 6 | (0.17) |
Total | 71 | (0.16) |
* Per 100,000 population for ABCs areas
Syndrome | Cases No. (%*) |
Deaths No. (Rate†) |
---|---|---|
Meningitis | 33 (46.5) | 3 (9.1) |
Bacteremia without focus | 15 (21.1) | 3 (20.0) |
* Percent of cases
† Per 100 cases with known outcome
Age (years) | Serogroup B No. (Rate*) |
Serogroup C No. (Rate*) |
Serogroup Y No. (Rate*) |
Serogroup Other‡ No. (Rate*) |
---|---|---|---|---|
< 1 | 3 (0.62) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
1 | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
2-4 | 1 (0.07) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
5-17 | 1 (0.01) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
18-34 | 3 (0.03) | 2 (0.02) | 1 (0.01) | 5 (0.05) |
35-49 | 2 (0.03) | 0 (0.00) | 1 (0.01) | 4 (0.05) |
50-64 | 6 (0.08) | 0 (0.00) | 4 (0.05) | 3 (0.04) |
65-74 | 1 (0.03) | 0 (0.00) | 2 (0.06) | 0 (0.00) |
75-84 | 1 (0.06) | 2 (0.13) | 1 (0.06) | 0 (0.00) |
≥ 85 | 0 (0.00) | 1 (0.14) | 0 (0.00) | 0 (0.00) |
Total† | 18 (0.05) | 5 (0.01) | 9 (0.02) | 12 (0.03) |
* Per 100,000 population for ABCs areas excluding Oregon
† Unknown serogroup (n=4) distributed amongst known. All rates exclude Oregon. Rates including Oregon are serogroup B 0.08, serogroup C 0.03, serogroup Y 0.03, and serogroup Other 0.03 per 100,000 population for ABCs areas
‡ Other includes serogroup W and nongroupables
Rates of Meningococcal Disease in Adolescents and Young Adults†
Age (years) | Overall Serogroups No. (Rate*) |
C/Y/W Serogroups No. (Rate*) |
---|---|---|
11-17 | 1 (0.03) | 0 (0.00) |
18-22 | 4 (0.15) | 0 (0.00) |
* Per 100,000 population for ABCs areas excluding Oregon
† All rates exclude Oregon. Rates including Oregon are, for 11-17 year olds, overall serogroups 0.03 and serogroup C/Y/W 0.00; for 18-22 year olds, overall serogroups 0.34 and serogroup C/Y/W 0.00 per 100,000 population for ABCs areas
National Estimates for Disease¥
Cases: 370 (0.14/100,000)
Deaths: 60 (0.02/100,000)
¥ In 2015, 372 cases of meningococcal disease (confirmed and probable) were reported to the National Notifiable Disease Surveillance System (incidence 0.12/100,000 population)
Healthy People 2020 Update
Objective: Reduce the incidence of meningococcal disease to 0.3 per 100,000 population.
2020 Objective | 2015 Rate* |
---|---|
0.3/100,000 | 0.11/100,000 |
* Per 100,000 U.S. population
Citation
Centers for Disease Control and Prevention. 2015. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2015.
Top of Page- Page last reviewed: March 23, 2017 (archived document)
- Content source: